TriageOPTIMTSNCT05473988
Optimization of Treatment Priority of the Manchester Triage System
An observational study of Triage, run by Kepler University Hospital at 1 site in Austria.
Trial summary
In the emergency department, the urgency for treating patients is determined according to the Manchester Triage System. The parameters collected in this process are deterministically translated into a treatment priority. Read more about this study
- Who is it for?
- Ages 18 to 120 years
- Conditions the study is for
- Triage
- What is being tested?
- Admission to General Ward, Admission to Intensive Care Unit and 30 Day Mortality
- How many people
- 77,976 participants
- Where
- 1 siteAustria
- Study dates
- 1 Jun 2022to 31 Jul 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 120 years
- All sexes
- Adult, Older adult
Study population: As described in the inclusion criteria.
Who may be able to join
- All adult patients that were triaged at the emergency department at the Kepler University Hospital in the period between 2015-12-01 to 2020-08-31.
Who cannot join
- None.
Trial locations and contacts
1 site in 1 country.
About this study
In the emergency department, the urgency for treating patients is determined according to the Manchester Triage System. The parameters collected in this process are deterministically translated into a treatment priority.
The Manchester Triage System (MTS), which has been in use for at least 20 years, is a widely used, validated and standardized procedure for initial assessment in the emergency department - this initial assessment (triage) is done to prioritize medical assistance at a central point. Especially in emergency situations, critically endangered patients often require the deployment of a large part of the available staff at the same time - the medically correct triage of patients according to objective criteria in order to enable an adequate allocation of the available resources at the right time is the main objective. In the optimal case, each patient is treated by medical professionals within the time frame that is adequate for his/her health condition.
Read more
Using artificial intelligence methods, it may be possible to increase the accuracy of treatment priority assignment. In the best case, incorrect prioritization of patients can be prevented and medical care can be ensured for those patients who actually need it most urgently.
However, initial assessment, even if standardized and validated, still runs under limited resource conditions - time, space, material and personnel. Last but not least, the very idea of conducting an initial assessment limits its validity, and the results of the allocation fluctuate according to current research, although the determinants of this are currently unknown.
- Conditions
- Triage
- Being tested
- Admission to General Ward, Admission to Intensive Care Unit, 30 Day Mortality
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Admission to General WardOther
Admission to General Ward
Admission to Intensive Care UnitOther
Admission to Intensive Care Unit
30 Day MortalityOther
30 Day Mortality
| Study group | Role | What they receive |
|---|---|---|
| Admission to General Ward Positive | Admission to General Ward Positive Receives: Other: Admission to General Ward | |
| 30 Day Mortality Positive | 30 Day Mortality Positive Receives: Other: 30 Day Mortality | |
| Admission to Intensive Care Unit Positive | Admission to Intensive Care Unit Positive Receives: Other: Admission to Intensive Care Unit | |
| Admission to General Ward Negative | Admission to General Ward Negative | |
| 30 Day Mortality Negative | 30 Day Mortality Negative | |
| Admission to Intensive Care Unit Negative | Admission to Intensive Care Unit Negative |
What is being measured
The primary outcome is the main question the study is designed to answer.
AUROC for Classification of Admission to General Ward
AUROC for Classification of Admission to General Ward
Measured: 2015-12-01 to 2020-08-31
AUROC for Classification of Admission to Intensive Care Unit
AUROC for Classification of Admission to Intensive Care Unit
Measured: 2015-12-01 to 2020-08-31
AUROC for Classification of 30 Day Mortality
AUROC for Classification of 30 Day Mortality
Measured: 2015-12-01 to 2020-08-31
Secondary outcomes (1)
Confusion Matrix
Confusion Matrix Results: true positives, true negatives, false positive, false negatives and values calculated from these results.
Measured: 2015-12-01 to 2020-08-31
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jul 2022
- Study start1 Jun 2022
- Primary completion31 Jul 2022
- Study completion31 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TriageStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 77,976 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kepler University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Thomas Tschoellitsch, MD, Principal investigator, Kepler University Hospital and Johannes Kepler University, Linz, Austria
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05473988
- Sponsor's protocol ID
- OPTIMTS
- Acronym
- OPTIMTS
- Status last verified
- Apr 2023
- First submitted
- 12 Jul 2022
- Last updated
- 3 May 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Optimization of Treatment Priority of the Manchester Triage System
- ClinicalTrials.gov ID
- NCT05473988
- Acronym / sponsor ID
- OPTIMTS / OPTIMTS
- Conditions
- Triage
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 77,976 participants (actual)
- Lead sponsor
- Kepler University HospitalUniversity, hospital or other
- Study start
- 1 Jun 2022 (actual)
- Primary completion
- 31 Jul 2022 (actual)
- Study completion
- 31 Jul 2022 (actual)
- First posted
- 26 Jul 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In the emergency department, the urgency for treating patients is determined according to the Manchester Triage System. The parameters collected in this process are deterministically translated into a treatment priority.
The Manchester Triage System (MTS), which has been in use for at least 20 years, is a widely used, validated and standardized procedure for initial assessment in the emergency department - this initial assessment (triage) is done to prioritize medical assistance at a central point. Especially in emergency situations, critically endangered patients often require the deployment of a large part of the available staff at the same time - the medically correct triage of patients according to objective criteria in order to enable an adequate allocation of the available resources at the right time is the main objective. In the optimal case, each patient is treated by medical professionals within the time frame that is adequate for his/her health condition.
Using artificial intelligence methods, it may be possible to increase the accuracy of treatment priority assignment. In the best case, incorrect prioritization of patients can be prevented and medical care can be ensured for those patients who actually need it most urgently.
However, initial assessment, even if standardized and validated, still runs under limited resource conditions - time, space, material and personnel. Last but not least, the very idea of conducting an initial assessment limits its validity, and the results of the allocation fluctuate according to current research, although the determinants of this are currently unknown.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| Admission to General Ward Positive | – | Other: Admission to General WardAdmission to General Ward Positive |
| 30 Day Mortality Positive | – | Other: 30 Day Mortality30 Day Mortality Positive |
| Admission to Intensive Care Unit Positive | – | Other: Admission to Intensive Care UnitAdmission to Intensive Care Unit Positive |
| Admission to General Ward Negative | – | –Admission to General Ward Negative |
| 30 Day Mortality Negative | – | –30 Day Mortality Negative |
| Admission to Intensive Care Unit Negative | – | –Admission to Intensive Care Unit Negative |
Who may qualify
- Ages
- 18 to 120 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- As described in the inclusion criteria.
Key inclusion criteria (1 listed)
- All adult patients that were triaged at the emergency department at the Kepler University Hospital in the period between 2015-12-01 to 2020-08-31.
Key exclusion criteria (1 listed)
- None.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Admission to General WardAdmission to General Ward | Other | Admission to General Ward Positive |
| Admission to Intensive Care UnitAdmission to Intensive Care Unit | Other | Admission to Intensive Care Unit Positive |
| 30 Day Mortality30 Day Mortality | Other | 30 Day Mortality Positive |
Primary outcome
AUROC for Classification of Admission to General Ward
Time frame: 2015-12-01 to 2020-08-31
AUROC for Classification of Admission to General Ward
AUROC for Classification of Admission to Intensive Care Unit
Time frame: 2015-12-01 to 2020-08-31
AUROC for Classification of Admission to Intensive Care Unit
AUROC for Classification of 30 Day Mortality
Time frame: 2015-12-01 to 2020-08-31
AUROC for Classification of 30 Day Mortality
1 secondary outcome
Confusion Matrix
Time frame: 2015-12-01 to 2020-08-31
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 May 2023.
- Individual participant dataSharing planned: No
Related trials for Triage
Recruiting
The Impact of Telemedicine, Using the Caller's Mobile Phone Camera, on the Quality of Care Provided to Adult Patients Contacting the 15 Centre for Acute Dyspnea
Dyspnea
Active, not recruiting
Clinical Trial for Integrated Care to Help At Risk Teens (iCHART) Intervention
Suicide and Depression, Adolescent Behavior
RecruitingPhase 2
Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
Metastatic Cancer, Cervical Cancer
Enrolling by invitationObservational study
Intestinal Obstruction Surgery. Acute Abdominal Pathology. №9:05/05/2026
Small Bowel Adhesion, Obstruction Bowel
RecruitingPhase 2
Immune-Mediated Pathophysiology And Clinical Triage Program
Arthritis, Arthralgia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Thomas Tschoellitsch, MD principal investigator
Kepler University Hospital and Johannes Kepler University, Linz, Austria
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Triage, run by Kepler University Hospital at 1 site in Austria.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
AUROC for Classification of Admission to General Ward (time frame: 2015-12-01 to 2020-08-31). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2023.